Source: International Congress 2018 – CC6 Interstitial lung diseases
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Matsubayashi (Tokyo, Japan). CT and FDG PET/CT findings of pulmonary involvement in methotrexate-associated lymphoproliferative disease. International Congress 2018 – CC6 Interstitial lung diseases

Member's Comments

No comment yet.

Related content which might interest you: The role of 18-FDG PET/CT in lung sarcoidosis Source: International Congress 2017 – The many faces of sarcoidosis Year: 2017 The Value of 18F-FDG PET/CT in evaluating disease severity in idiopathic pulmonary fibrosis Source: International Congress 2017 – ILDs: clinical aspects Year: 2017 The usefulness of dynamic CT and 18F-FDG PET to distinguish between benignancy and malignancy in solitary pulmonary nodule Source: Eur Respir J 2007; 30: Suppl. 51, 532s Year: 2007 Comparison of chest x-ray, thoracic computed tomography and 18F-FDG PET/CT for staging of sarcoidosis Source: International Congress 2015 – Sarcoidosis: clinical Year: 2015 Evaluation of pleural disease with FDG-PET imaging Source: Annual Congress 2003 - Early lung cancer diagnosis Year: 2003 The utility of 18F-FDG PET/CT in chronic sarcoidosis Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis Year: 2013 18F-fluorodeoxyglucose (18F-FDG) PET/CT assessment of aortic inflammation and calcification in COPD Source: International Congress 2017 – Imaging markers for COPD and asthma Year: 2017 Utility of FDG-PET in the diagnosis of pulmonary nodules Source: Eur Respir J 2003; 22: Suppl. 45, 245s Year: 2003 Computed tomography findings of pulmonary nocardiosis at diagnosis Source: Annual Congress 2012 - CT findings: educational posters Year: 2012 Use of integrated FDG PET/CT imaging in pulmonary cacinoid tumors Source: Eur Respir J 2006; 28: Suppl. 50, 775s Year: 2006 The 18F PET/CT scan in patients with chronic sarcoidosis Source: International Congress 2016 – Sarcoidosis Year: 2016 Does positron emission tomography (PET/CT) have a role to play in the management of patients presenting with pleural changes suggestive of malignancy Source: Annual Congress 2009 - Diagnosis and management of pleural effusions and mesothelioma: improving old techniques and new tools Year: 2009 18 F-FDG PET/CT findings mimicking malignant disease in patients with pneumoconiosis (due to 4 cases) Source: Annual Congress 2009 - Management of thoracic malignancies Year: 2009 Chest CT findings in IgG4-related diseases Source: Annual Congress 2010 - Clinical aspects and treatment of asthma and allergic respiratory diseases Year: 2010 Pulmonary ANCA-associated vasculitis mimicking a lung tumour or diffuse lung metastases (with positive PET-CT scan) Source: International Congress 2018 – CC5 Pulmonary vasculitis: the great chameleon Year: 2018 Prognostic value of dual-time-point 18F-FDG PET in fibrotic idiopathic interstitial pneumonia Source: Annual Congress 2013 –Diffuse pulmonary fibrosis Year: 2013 Use of integrated FDG PET/CT imaging in sarcoidosis Source: Eur Respir J 2006; 28: Suppl. 50, 542s Year: 2006 CT safety issues Source: Research Seminar 2006 - Preventing respiratory sequelae in children diagnosed with cystic fibrosis by newborn screening Year: 2006 Increased FDG uptake on 18F-FDG PET/CT in residual lesions of tuberculosis Source: International Congress 2019 – Tuberculosis: from diagnosis to complications Year: 2019 CT imaging manifestations of pulmonary tuberculosis Source: Eur Respir J 2006; 28: Suppl. 50, 847s Year: 2006